MedTrace Logo

"Learning About Biologics"-Rheumatoid Arthritis

NCT01721200 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2018-02-19

Study results available
· View outcomes & findings →

Summary

This study is a randomized controlled trial designed to examine the efficacy of an educational decision support tool for patients with rheumatoid arthritis who continue to have active disease despite use of traditional disease modifying drugs. The study will take place at Geisinger Medical Center in Danville, PA. Eligible subjects will be identified by the treating physician and those providing consent will be randomized to usual care versus use of the decision support tool.

Conditions

Interventions

OTHER

Decision Support Tool

Educational decision support tool for patients with rheumatoid arthritis

OTHER

Usual Care

Subjects randomized to the Usual Care Group will receive their biologic drug teaching from the rheumatologist as part of their routine care.

Sponsors & Collaborators

  • Yale University

    collaborator OTHER

  • Geisinger Clinic

    lead OTHER

Principal Investigators

  • Liana Fraenkel, MD, MPH · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01721200 on ClinicalTrials.gov